(Q35693770)

9 August 2017

1 reference

title

Tibolone: a unique version of hormone replacement therapy (English)

1 reference

9 August 2017

John M Swegle

1

1 reference

9 August 2017

Michael W Kelly

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

16 March 2004

1 reference

Annals of Pharmacotherapy

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

874-881

1 reference

Tibolone: a steroid with a tissue-specific mode of action

9 August 2017

cites work

1 reference

Tibolone for postmenopausal women: systematic review of randomized trials

21 January 2018

1 reference

In vitro studies of tibolone in breast cells.

21 January 2018

1 reference

The in vivo human metabolism of tibolone

21 January 2018

1 reference

A pilot study of hormone replacement therapy with tibolone in women with mastopathic breasts

21 January 2018

1 reference

Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite

21 January 2018

1 reference

Pharmacokinetics of tibolone in early and late postmenopausal women

21 January 2018

1 reference

Prospective, randomised study with three HRT regimens in postmenopausal women with an intact uterus

21 January 2018

1 reference

Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women

21 January 2018

1 reference

Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor

21 January 2018

1 reference

Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies

21 January 2018

1 reference

The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women.

21 January 2018

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density

21 January 2018

1 reference

Breast mammographic pattern: a concatenation of confounding and breast cancer risk factors

21 January 2018

1 reference

A comparison of the effects of two continuous HRT regimens on cardiovascular risk factors

21 January 2018

1 reference

A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.

21 January 2018

1 reference

Effects of tibolone on plasma homocysteine levels in postmenopausal women

21 January 2018

1 reference

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D462

1 reference

9 August 2017

1 reference